Brain tech startup Science Corp. raised $230M, a source says at a $1.5B valuation, taking its total funding to $489M, to commercialize its implant for blindness
Neurotechnology company Science Corp. raised $230 million from investors to commercialize its implant for blindness and develop even more advanced brain devices.
Bloomberg Ike Swetlitz
Related Coverage
- Science Corp raises $230M as it races to bring its brain implant to market TechCrunch · Connie Loizos
- Neuralink Rival Science Raises $230 Million for Eye Implant Bloomberg Law · Ike Swetlitz
- 🧠 BRAIN SCOOP: Brain technology company Science raised $230 million. It's developing a retinal implant to treat blindness. … Ike Swetlitz
- Today is a big day for Science. — I am excited to share that in less than 30 days -and only a few weeks after joining … Darius Shahida
- We've closed a $230 million Series C financing with participation from Khosla Ventures, Lightspeed, Y Combinator, IQT, and Quiet Capital, all pre-existing investors in Science, among others. linkedin.com
- Science Corporation: $230 Million Raised To Commercialize Vision-Restoring BCI Retinal Implant Pulse 2.0 · Amit Chowdhry
- Science Closes $230 Million Series C to Fund Commercialization of PRIMA BCI Retinal Implant and Expansion of Clinical Trials Science Corporation
- We're proud to announce our participation in the $230M Series C financing of Science, alongside an incredible group of investors. … RRE Ventures
- Science is advancing one of the most promising frontiers in neurotechnology. — The company's oversubscribed $225M Series C will accelerate commercialization … IQT
- Remarkable what Science is building. 80% of patients in their trials who had no other options are reading again. Excited to continue the partnership 🧠 Ben Mahdavi
- #Braincomputerinterfaces #BCIs are one of the most exciting spaces in #medtech right now. This Series C nearly doubles the total amount Science has raised. … Chris Newmarker
Discussion
-
@maxhodak_
Max Hodak
on x
excited to announce that we've raised a $230 million series c to get our retinal prosthesis to market and our biohybrid and vessel technologies into the clinic!
-
@sciencecorp_
@sciencecorp_
on x
We've closed a $230 million Series C financing with participation from @khoslaventures, @lightspeedvp, @ycombinator, IQT, and @QuietCapital, all pre-existing investors in Science, among others. [image]
-
@paulbz
Paul Murphy
on x
Excited to back Science @lightspeedvp. PRIMA restores vision in patients blinded by macular degeneration, launching in Europe this year w/ a much bigger neural engineering platform behind it. Great getting to know @maxhodak_ this past year. Deeply scientific w/ ability to ship. […